• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Gilead Sciences (NQ: GILD )

    72.41 -0.15 (-0.21%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 22, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 6,420,758
    Open 72.89
    Bid (Size) 72.41 (8)
    Ask (Size) 72.71 (14)
    Prev. Close 72.56
    Today's Range 72.02 - 73.32
    52wk Range 62.07 - 87.86
    Shares Outstanding 1,253,809,440
    Dividend Yield 4.14%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    AnaptysBio Investigational Arthritis Drug Might Have Better Efficacy Profile Than Eli Lilly's: Analyst
    HC Wainwright initiated coverage on AnaptysBio with a Buy rating and a $55 price target. AnaptysBio focuses on immunology therapeutics with a promising pipeline. 
    Via Benzinga
    Biotech Bull Market Is Intact But SMIDs Are Too Volatile
    It was another wild week for the market as it had to contend with a lot of news. 
    Via Talk Markets

    Performance

    YTD
    -13.01%
    -13.01%
    1 Month
    +2.46%
    +2.46%
    3 Month
    +8.16%
    +8.16%
    6 Month
    -7.68%
    -7.68%
    1 Year
    -6.76%
    -6.76%

    More News

    Read More
    Breaking Down Gilead Sciences: 10 Analysts Share Their Views
    Via Benzinga
    Gilead and the Elton John AIDS Foundation Announce Additional Five Years of RADIAN Partnership to Help Address the Growing HIV Crisis in Eastern Europe and Central Asia
    From Gilead Sciences, Inc.
    Via Business Wire
    Check Out What Whales Are Doing With GILD
    Via Benzinga
    Gilead Sciences's Options Frenzy: What You Need to Know
    Via Benzinga
    Looking Into Gilead Sciences's Recent Short Interest
    Via Benzinga
    If You Invested $1000 In This Stock 20 Years Ago, You Would Have $8,400 Today
    Via Benzinga
    This Hidden Gem Vanguard ETF Is Chock-Full of Magnificent Stocks. Here's Why It's a Buy Now.
    Via The Motley Fool
    Topics ETFs
    If You Can Only Buy One Biotech Stock in July, It Better Be One of These 3 Names
    Via InvestorPlace
    Chief Medical Officer Merdad Parsey to Leave Gilead Early 2025
    From Gilead Sciences, Inc.
    Via Business Wire
    Want $3,000 In Passive Income? Invest $51,000 in These 3 High-Yield Dividend Plays
    Via The Motley Fool
    Gilead to Highlight Landmark Progress in Research Across HIV Prevention, Treatment and Cure Programs at AIDS 2024
    From Gilead Sciences, Inc.
    Via Business Wire
    The 3 Most Undervalued Nasdaq 100 Stocks to Buy in July 2024
    Via InvestorPlace
    Positive News is Driving This Cancer Drug Maker’s Stock Higher
    Via MarketBeat
    3 Dividend Growth Stocks to Buy and Hold
    Via The Motley Fool
    Is Iovance Biotherapeutics a Millionaire Maker?
    Via The Motley Fool
    The 7 Most Undervalued Healthcare Stocks to Buy in July 2024
    Via InvestorPlace
    3 Underappreciated Stocks About to Break Their Chains
    Via InvestorPlace
    Oil Declines Amid Prospects Of An Agreement Between Israel And Hamas. Powell Will Address The Us Congress Today
    Via Talk Markets
    Topics Stocks
    Exposures US Equities
    7 Cheap Biotech Stocks With Major Upside Potential
    Via InvestorPlace
    Healthcare Stocks Continue To Lag The Market-Can Anything Help ?
    Via Talk Markets
    This Domino's Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
    Via Benzinga
    Amgen, Inc. Dividend Stock Analysis
    Via Talk Markets
    FDA Favorites: 3 Biotech Stocks on the Verge of Major Approvals
    Via InvestorPlace
    Exposures Product Safety
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.